MOPAX
Price
$35.93
Change
-$0.07 (-0.19%)
Updated
Jul 31 closing price
Net Assets
343.12M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MOPAX vs NAESX

MOPAX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
MOPAX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOPAX is a StrongBuy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. MOPAX (343M). NAESX pays higher dividends than MOPAX: NAESX (1.10) vs MOPAX (0.02). MOPAX was incepted earlier than NAESX: MOPAX (23 years) vs NAESX (66 years). MOPAX (1.20) is less costly to investors than NAESX (0.17). MOPAX is a more actively managed with annual turnover of: 77.00 vs. NAESX (17.00). NAESX has a lower initial minimum investment than MOPAX: NAESX (0) vs MOPAX (15000). MOPAX annual gain was more profitable for investors over the last year : 45.73 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. MOPAX (15.15).
MOPAXNAESXMOPAX / NAESX
Total Expense Ratio1.200.17706%
Annual Report Gross Expense Ratio1.200.17706%
Fund Existence23 years66 years-
Gain YTD25.56914.563176%
Front Load6%N/A-
Min. Initial Investment150000-
Min. Initial Investment IRAN/AN/A-
Net Assets343M189B0%
Annual Yield % from dividends0.021.102%
Returns for 1 year45.7322.56203%
Returns for 3 years66.2943.30153%
Returns for 5 years15.1534.9543%
Returns for 10 years37.71155.2824%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv